Literature DB >> 29180644

Genome editing for the reproduction and remedy of human diseases in mice.

Satoshi Hara1, Shuji Takada2.   

Abstract

With the recent progress in genome-editing technologies, such as the CRISPR/Cas9 system, genetically modified animals carrying nucleotide substitutions or large chromosomal rearrangements can be produced rapidly and at low cost. Such genome-editing techniques have been applied in the generation of animal models, especially mice, for reproducing human disease mutations, such as single-nucleotide polymorphisms (SNPs) or large chromosomal rearrangements identified by genome-wide screening analyses. While application methods are under development for various complex mutations involving genome editing for mimicking human disease-causing mutations in mice, functional studies of mouse models carrying replicated human mutations are gradually being published. In this review, we discuss the recent progress in application methods of the CRISPR/Cas9 system, focusing on the production of mouse models of diseases.

Entities:  

Mesh:

Year:  2017        PMID: 29180644     DOI: 10.1038/s10038-017-0360-4

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  36 in total

1.  Loss of function mutation in LOX causes thoracic aortic aneurysm and dissection in humans.

Authors:  Vivian S Lee; Carmen M Halabi; Erin P Hoffman; Nikkola Carmichael; Ignaty Leshchiner; Christine G Lian; Andrew J Bierhals; Dana Vuzman; Robert P Mecham; Natasha Y Frank; Nathan O Stitziel
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-18       Impact factor: 11.205

2.  Deletions, Inversions, Duplications: Engineering of Structural Variants using CRISPR/Cas in Mice.

Authors:  Katerina Kraft; Sinje Geuer; Anja J Will; Wing Lee Chan; Christina Paliou; Marina Borschiwer; Izabela Harabula; Lars Wittler; Martin Franke; Daniel M Ibrahim; Bjørt K Kragesteen; Malte Spielmann; Stefan Mundlos; Darío G Lupiáñez; Guillaume Andrey
Journal:  Cell Rep       Date:  2015-02-07       Impact factor: 9.423

3.  Generation of gene-modified mice via Cas9/RNA-mediated gene targeting.

Authors:  Bin Shen; Jun Zhang; Hongya Wu; Jianying Wang; Ke Ma; Zheng Li; Xueguang Zhang; Pumin Zhang; Xingxu Huang
Journal:  Cell Res       Date:  2013-04-02       Impact factor: 25.617

4.  Efficient in vivo gene editing using ribonucleoproteins in skin stem cells of recessive dystrophic epidermolysis bullosa mouse model.

Authors:  Wenbo Wu; Zhiwei Lu; Fei Li; Wenjie Wang; Nannan Qian; Jinzhi Duan; Yu Zhang; Fengchao Wang; Ting Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-30       Impact factor: 11.205

5.  Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells.

Authors:  Van Trung Chu; Timm Weber; Benedikt Wefers; Wolfgang Wurst; Sandrine Sander; Klaus Rajewsky; Ralf Kühn
Journal:  Nat Biotechnol       Date:  2015-03-24       Impact factor: 54.908

6.  Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex.

Authors:  Travis H Stracker; Christian T Carson; Matthew D Weitzman
Journal:  Nature       Date:  2002-07-18       Impact factor: 49.962

7.  An inhibitor of nonhomologous end-joining abrogates double-strand break repair and impedes cancer progression.

Authors:  Mrinal Srivastava; Mridula Nambiar; Sheetal Sharma; Subhas S Karki; G Goldsmith; Mahesh Hegde; Sujeet Kumar; Monica Pandey; Ram K Singh; Pritha Ray; Renuka Natarajan; Madhura Kelkar; Abhijit De; Bibha Choudhary; Sathees C Raghavan
Journal:  Cell       Date:  2012-12-21       Impact factor: 41.582

8.  Large genomic fragment deletion and functional gene cassette knock-in via Cas9 protein mediated genome editing in one-cell rodent embryos.

Authors:  Liren Wang; Yanjiao Shao; Yuting Guan; Liang Li; Lijuan Wu; Fangrui Chen; Meizhen Liu; Huaqing Chen; Yanlin Ma; Xueyun Ma; Mingyao Liu; Dali Li
Journal:  Sci Rep       Date:  2015-12-01       Impact factor: 4.379

9.  Efficient and rapid generation of large genomic variants in rats and mice using CRISMERE.

Authors:  Marie-Christine Birling; Laurence Schaeffer; Philippe André; Loic Lindner; Damien Maréchal; Abdel Ayadi; Tania Sorg; Guillaume Pavlovic; Yann Hérault
Journal:  Sci Rep       Date:  2017-03-07       Impact factor: 4.379

10.  Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo.

Authors:  Hao Yin; Chun-Qing Song; Joseph R Dorkin; Lihua J Zhu; Yingxiang Li; Qiongqiong Wu; Angela Park; Junghoon Yang; Sneha Suresh; Aizhan Bizhanova; Ankit Gupta; Mehmet F Bolukbasi; Stephen Walsh; Roman L Bogorad; Guangping Gao; Zhiping Weng; Yizhou Dong; Victor Koteliansky; Scot A Wolfe; Robert Langer; Wen Xue; Daniel G Anderson
Journal:  Nat Biotechnol       Date:  2016-02-01       Impact factor: 54.908

View more
  5 in total

Review 1.  Model organism data evolving in support of translational medicine.

Authors:  Douglas G Howe; Judith A Blake; Yvonne M Bradford; Carol J Bult; Brian R Calvi; Stacia R Engel; James A Kadin; Thomas C Kaufman; Ranjana Kishore; Stanley J F Laulederkind; Suzanna E Lewis; Sierra A T Moxon; Joel E Richardson; Cynthia Smith
Journal:  Lab Anim (NY)       Date:  2018-09-17       Impact factor: 12.625

Review 2.  Fshb Knockout Mouse Model, Two Decades Later and Into the Future.

Authors:  T Rajendra Kumar
Journal:  Endocrinology       Date:  2018-05-01       Impact factor: 4.736

Review 3.  Generating mouse models for biomedical research: technological advances.

Authors:  Channabasavaiah B Gurumurthy; Kevin C Kent Lloyd
Journal:  Dis Model Mech       Date:  2019-01-08       Impact factor: 5.758

4.  Therapies for epidermolysis bullosa: delivery is key.

Authors:  J Bremer; P C van den Akker
Journal:  Br J Dermatol       Date:  2019-01       Impact factor: 9.302

5.  Dominant negative Gfi1b mutations cause moderate thrombocytopenia and an impaired stress thrombopoiesis associated with mild erythropoietic abnormalities in mice.

Authors:  Hugues Beauchemin; Peiman Shooshtharizadeh; Jordan Pinder; Graham Dellaire; Tarik Möröy
Journal:  Haematologica       Date:  2020-10-01       Impact factor: 9.941

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.